论文部分内容阅读
目的:检验脂多糖结合蛋白(LBP)可用作冠状动脉疾病(CAD)生物学标记物的假说。背景:病原体的先天免疫识别可致动脉粥样硬化的机制仍不明了。LBP是第
PURPOSE: To test the hypothesis that lipopolysaccharide binding protein (LBP) can be used as a biomarker of coronary artery disease (CAD). Background: The mechanism by which innate immunity of pathogens can cause atherosclerosis remains unclear. LBP is the first